Aprea Therapeutics, Inc. Form 8-K Summary
Filing date: March 26, 2020
Reporting period: Fourth quarter and year ended December 31, 2019
Primary item: Item 2.02, Results of Operations and Financial Condition
Business Context
Aprea Therapeutics, Inc. furnished a press release announcing its fourth-quarter and full-year 2019 financial results and providing an operations update. The filing identifies the company as an emerging growth company whose common stock trades on the Nasdaq Global Select Market under the symbol APRE.
Financial Results and Key Metrics
The filing text states that the accompanying press release contains the financial results, but the press release itself is not included in the provided text. Revenue, net loss, cash flow, margins, debt, liquidity, cash balance, and other financial metrics are therefore not clearly available from this filing excerpt.
Material Changes Versus Prior Period
The filing announces results for the fourth quarter and year ended December 31, 2019, but does not provide comparative figures or a quantified discussion of changes versus the prior comparable periods.
Guidance, Outlook, Risks, and Unusual Items
The filing references an update on the company’s operations for the same period. No guidance, outlook, risk factors, contingencies, or unusual items are described in the provided filing text. The details may be contained in Exhibit 99.1, the referenced March 26, 2020 press release, which is not reproduced here.
Important Facts to Verify
- Verify the complete Exhibit 99.1 press release for fourth-quarter and full-year 2019 revenue, net loss, operating expenses, cash flow, and liquidity.
- Verify the company’s cash runway, financing requirements, and any debt or capital-raising activity.
- Review management’s operational update, clinical-development progress, and forward-looking statements.
- Confirm any material changes from the fourth quarter and full year of 2018.
- Note that the Item 2.02 information and Exhibit 99.1 were furnished, not filed, for purposes of Section 18 liability and generally were not incorporated by reference into other filings absent specific reference.